Vistagen Therapeutics, Inc. - VTGN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | StemPoint Capital LP | 1.5% | 616,749 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | StemPoint Capital Management GP LLC | 1.5% | 616,749 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Michelle Ross | 1.5% | 616,749 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ORBIMED ADVISORS LLC | 3.6% | 1,420,300 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ORBIMED CAPITAL LLC | 4.2% | 1,639,700 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Great Point Partners, LLC | 4.95% | 2,055,834 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 4.95% | 2,055,834 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 4.95% | 2,055,834 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 9.9% | 4,383,508 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 9.9% | 4,383,508 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 9.9% | 4,383,508 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Michael Kramarz | 9.9% | 4,383,508 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 4.71% | 1,953,045 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 4.71% | 1,953,045 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 4.71% | 1,953,045 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 4.62% | 1,824,738 | View |
| Nov 14, 2025 | SCHEDULE 13G | ORBIMED ADVISORS LLC | 4.63% | 1,420,300 | View |
| Nov 14, 2025 | SCHEDULE 13G | ORBIMED CAPITAL LLC | 5.34% | 1,639,700 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 3,185,564 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 3,185,564 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 3,185,564 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Great Point Partners, LLC | 6.28% | 2,055,834 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 6.28% | 2,055,834 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 6.28% | 2,055,834 | View |
| Oct 31, 2025 | SCHEDULE 13G/A | The Vanguard Group | 5.5% | 1,687,735 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.